Simplex Trading, LLC Clearside Biomedical, Inc. Transaction History

Simplex Trading, LLC

$175 Billion
Q2 2025

A detailed history of Simplex Trading, LLC transactions in Clearside Biomedical, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 127 shares of CLSD stock, worth $510. This represents 0.0% of its overall portfolio holdings.

Number of Shares

127

Holding current value

$510

% of portfolio

0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 05, 2025	BUY	$0.74 - $0.93 $93 - $118	127 New	127 $0
Q3 2024 Nov 08, 2024	SELL	$0.93 - $1.35 $2,055 - $2,983	-2,210 Reduced 33.31%	4,424 $5,000
Q2 2024 Jul 25, 2024	BUY	$1.08 - $1.58 $1,409 - $2,061	1,305 Added 24.49%	6,634 $8,000
Q1 2024 Apr 25, 2024	SELL	$1.2 - $2.02 $7,393 - $12,445	-6,161 Reduced 53.62%	5,329 $8,000
Q4 2023 Feb 02, 2024	BUY	$0.68 - $1.18 $4,515 - $7,836	6,641 Added 136.96%	11,490 $13,000
Q3 2023 Nov 01, 2023	BUY	$0.82 - $1.27 $2,196 - $3,402	2,679 Added 123.46%	4,849 $4,000
Q2 2023 Aug 04, 2023	BUY	$0.97 - $1.48 $2,104 - $3,211	2,170 New	2,170 $2,000
Q3 2022 Nov 04, 2022	SELL	$1.08 - $1.83 $2,163 - $3,665	-2,003 Reduced 7.57%	24,458 $27,000
Q2 2022 Aug 03, 2022	BUY	$1.3 - $2.49 $23,743 - $45,477	18,264 Added 222.81%	26,461 $38,000
Q1 2022 May 02, 2022	BUY	$1.35 - $2.88 $2,943 - $6,278	2,180 Added 36.23%	8,197 $18,000
Q4 2021 Feb 23, 2022	BUY	$2.72 - $5.72 $16,366 - $34,417	6,017 New	6,017 $16,000
Q1 2021 Apr 26, 2021	SELL	$2.24 - $4.25 $10,304 - $19,550	-4,600 Closed	0 $0
Q4 2020 Feb 02, 2021	BUY	$1.32 - $2.74 $6,072 - $12,604	4,600 New	4,600 $0
Q3 2020 Oct 14, 2020	SELL	$1.45 - $2.0 $20,305 - $28,008	-14,004 Closed	0 $0
Q2 2020 Jul 13, 2020	SELL	$1.55 - $2.41 $1,709 - $2,658	-1,103 Reduced 7.3%	14,004 $26,000
Q1 2020 Apr 29, 2020	SELL	$1.32 - $3.77 $80,207 - $229,076	-60,763 Reduced 80.09%	15,107 $25,000
Q4 2019 Feb 05, 2020	BUY	$0.62 - $3.4 $46,759 - $256,421	75,418 Added 16685.4%	75,870 $220,000
Q3 2019 Oct 15, 2019	SELL	$0.59 - $1.32 $7 - $15	-12 Reduced 2.59%	452 $0
Q2 2019 Jul 26, 2019	BUY	$0.97 - $1.42 $450 - $658	464 New	464 $0
Q1 2019 Apr 18, 2019	SELL	$1.1 - $1.74 $4,005 - $6,335	-3,641 Closed	0 $0
Q4 2018 Jan 16, 2019	SELL	$1.0 - $6.12 $1,386 - $8,482	-1,386 Reduced 27.57%	3,641 $3,000
Q3 2018 Oct 23, 2018	SELL	$6.03 - $11.24 $143,719 - $267,894	-23,834 Reduced 82.58%	5,027 $30,000
Q2 2018 Jul 30, 2018	BUY	$8.91 - $14.54 $257,151 - $419,638	28,861 New	28,861 $308,000

Others Institutions Holding CLSD

# of Institutions

Shares Held

11.4M

Call Options Held

Put Options Held

Act Capital Management, LLC Wayne, PA

2.2M
Shares

$8.83 Million
3.43% of portfolio
Carmignac Gestion Paris, I0

1.51M
Shares

$6.06 Million
0.02% of portfolio
Black Rock Inc. New York, NY

798K
Shares

$3.21 Million
0.0% of portfolio
Geode Capital Management, LLC Boston, MA

790K
Shares

$3.18 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

497K
Shares

$2 Million
0.0% of portfolio

View Full List

About Clearside Biomedical, Inc.

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $242M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

More about CLSD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account